XML 36 R7.htm IDEA: XBRL DOCUMENT v2.4.0.8
Unaudited Condensed Consolidated Statements Of Cash Flows (USD $)
In Thousands, unless otherwise specified
9 Months Ended
Jun. 30, 2014
Jun. 30, 2013
Cash flows from operating activities:    
Net income $ 228,622 $ 248,331
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation 107,376 86,412
Amortization of debt issuance costs and bond premium, net 3,389 3,083
Amortization of deferred items 2,487 1,227
Provision for doubtful accounts 679 3,510
Provision for inventory obsolescence 1,226 1,530
Deferred income tax benefit (649) (605)
Share-based compensation expense 10,924 10,418
Gain on sale of assets (34,072) 0
Other, net 1,990 (67)
Changes in assets and liabilities:    
Accounts receivable (5,069) (18,297)
Income tax receivable (1,425) (1,391)
Inventory (8,816) (22,065)
Prepaid expenses 14,100 12,788
Deferred costs and other assets (10,512) (9,519)
Accounts payable (11,303) (10,970)
Accrued liabilities 15,127 (6,745)
Bond premium 0 8,500
Income tax payable 6,032 6,311
Deferred credits and other liabilities 21,141 9,989
Net cash provided by operating activities 341,247 322,440
Cash flows from investing activities:    
Capital expenditures (564,119) (569,696)
Proceeds from sale of assets 59,516 129
Net cash used in investing activities (504,603) (569,567)
Cash flows from financing activities:    
Proceeds from issuance of bonds 0 200,000
Proceeds from bank credit facilities 370,000 400,000
Principal payments on bank credit facilities (165,000) (100,000)
Principal payments on notes payable (8,071) (5,148)
Repurchase and retirement of common shares 0 (107,260)
Proceeds from exercise of stock options 3,468 6,451
Debt issuance costs paid (6,650) (2,910)
Net cash provided by financing activities 193,747 391,133
Net increase in cash and cash equivalents 30,391 144,006
Cash and cash equivalents, at beginning of period 88,770 77,871
Cash and cash equivalents, at end of period 119,161 221,877
Non-cash activities:    
Changes in accounts payable and accrued liabilities related to capital expenditures $ (13,573) $ (15,011)